2016•Breast CancerRequires access

KLF4 and NANOG are prognostic biomarkers for triple-negative breast cancer

Takuya Nagata, Yutaka Shimada, Shinichi Sekine, Makoto Moriyama, Isaya Hashimoto, Koshi Matsui, Tomoyuki Okumura, Takashi Hori, Johji Imura, Kazuhiro Tsukada

Open publisher page 64 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 64 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Homeobox protein NANOG, KLF4, Triple-negative breast cancer, Medicine, Cancer research, Oncology, Breast cancer, Internal medicine

Back to paper search Browse research topics Original source

KLF4 and NANOG are prognostic biomarkers for triple-negative breast cancer — Research Paper | ScholarLens